330 related articles for article (PubMed ID: 35296203)
1. Echinocandins - structure, mechanism of action and use in antifungal therapy.
Szymański M; Chmielewska S; Czyżewska U; Malinowska M; Tylicki A
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):876-894. PubMed ID: 35296203
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
Martín Mazuelos E; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():7-13. PubMed ID: 19572429
[TBL] [Abstract][Full Text] [Related]
3. Echinocandins: The Expanding Antifungal Armamentarium.
Aguilar-Zapata D; Petraitiene R; Petraitis V
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.
Fiori B; Posteraro B; Torelli R; Tumbarello M; Perlin DS; Fadda G; Sanguinetti M
Antimicrob Agents Chemother; 2011 Jun; 55(6):3031-5. PubMed ID: 21422210
[TBL] [Abstract][Full Text] [Related]
5. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
6. [Echinocandins].
Cortés L JA; Russi N JA
Rev Chilena Infectol; 2011 Dec; 28(6):529-36. PubMed ID: 22286675
[TBL] [Abstract][Full Text] [Related]
7. The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.
Hinske LC; Weis F; Heyn J; Hinske P; Beiras-Fernandez A
Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):1-7. PubMed ID: 22044354
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of properties and clinical efficacy of the echinocandins.
Kim R; Khachikian D; Reboli AC
Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
[TBL] [Abstract][Full Text] [Related]
9. Natural products targeting the synthesis of β(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings.
Curto MÁ; Butassi E; Ribas JC; Svetaz LA; Cortés JCG
Phytomedicine; 2021 Jul; 88():153556. PubMed ID: 33958276
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antifungal activity of micafungin].
Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
[TBL] [Abstract][Full Text] [Related]
11. The echinocandins: three useful choices or three too many?
Bal AM
Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin: when and how? The microbiologist's view.
Mayr A; Aigner M; Lass-Flörl C
Mycoses; 2012 Jan; 55(1):27-35. PubMed ID: 21668518
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis.
Fleischhacker M; Radecke C; Schulz B; Ruhnke M
Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):127-31. PubMed ID: 18057972
[TBL] [Abstract][Full Text] [Related]
16. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D
J Clin Microbiol; 2011 Feb; 49(2):624-9. PubMed ID: 21147948
[TBL] [Abstract][Full Text] [Related]
17. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
Catalán-González M; Carlos Montejo-González J
Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
[TBL] [Abstract][Full Text] [Related]
20. Echinocandins--new antifungal agents.
Stan CD; Tuchiluş C; Stan CI
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):528-36. PubMed ID: 25076727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
